In fact, Id-2 has also been shown to be upregulated in prostate cancer (Coppe et al, 2004; Yuen et al, 2006), whereas Id proteins have been shown to co-express and have redundant roles in some cellular contexts (Lyden et al, 1999). This evidence concerns the gene ID2 and prostate carcinoma.